0001062993-16-007480 Sample Contracts

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT

Development and License Agreement • February 5th, 2016 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York

• Contract Type
  Development and License Agreement
• Filed
  February 5th, 2016
• Company
  Biospecifics Technologies Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT dated January ___, 2016, with an effective date as of January 1, 2016 (the “First Amendment Effective Date”), is by and between BioSpecifics Technologies Corp., a Delaware corporation (“BTC”), and Endo Global Ventures, a Bermuda unlimited liability company. BTC and Endo shall sometimes be referred to herein collectively as “Parties.”